---
title: "SCN1B"
date: 2023-05-15 00:00:00
layout: post
categories: Gene
summary: "# Gene SCN1B"
tags: ['SCN1B', 'NeurologicalDisorders', 'SodiumChannels', 'Epilepsy', 'Autism', 'Schizophrenia', 'DrugResponse', 'Prognosis']
---

# Gene SCN1B

## Genetic Position

The SCN1B gene is located on chromosome 19q13.1 and spans over 85 kb. It contains 11 exons and encodes for sodium channel β1 subunit.

## Pathology

SCN1B gene mutations have been associated with various neurological disorders, including epilepsy, autism, and schizophrenia. The mutations in SCN1B lead to disrupted cellular ion homeostasis by affecting the function of voltage-gated sodium channels.

## Function

The SCN1B gene encodes for a protein that acts as an auxiliary subunit of sodium channels in the brain and heart. It interacts with the α subunit of the sodium channel and helps in the proper folding, assembly, and trafficking of the channel complex.

## External IDs and Aliases

- HGNC: 10585
- NCBI Entrez Gene: 6323
- Ensembl: ENSG00000105699
- OMIM: 600235
- UniProtKB/Swiss-Prot: O60939
- Other aliases: ATL, FHM3, Navbeta1

## AA Mutation List and Mutation Type with dbSNP ID

Here's a list of some common SCN1B gene mutations with their corresponding amino acid changes and mutation types. 

| Mutation             | Amino acid change  | Mutation type | dbSNP ID  |
|----------------------|-----------------------|----------------|-----------|
| c.586G>A            | p.R196H                 | Missense       | rs121917892 |
| c.1639C>T          | p.P547L                 | Missense       | rs121917893 |
| c.2047-2A>G      | N/A                        | Splice site     | rs121917894 |
| c.1163G>A          | p.G388R                 | Missense       | rs121917895 |
| c.1340A>G         | N/A                        | Splice site     | rs121917896 |

## Somatic SNVs/InDels with dbSNP ID

Currently, there are no reported somatic mutations in SCN1B gene.

## Related Disease

Mutations in SCN1B gene have been associated with various neurological disorders, including:

- Generalized epilepsy with febrile seizures plus (GEFS+)
- Dravet syndrome
- Autism spectrum disorders (ASD)
- Schizophrenia

## Treatment and Prognosis

Treatment options for disorders associated with SCN1B gene mutations vary based on the specific condition and individual needs. Anticonvulsant medications, such as sodium channel blockers, may be used to manage seizures associated with epilepsy. However, the prognosis heavily depends on the severity of the disorder and its associated symptoms.

## Drug Response

Studies have shown that SCN1B gene mutations may affect the efficacy of certain drugs used for the treatment of epilepsy. For example, patients with Dravet syndrome carrying SCN1B mutations showed a poor response to carbamazepine, which is a commonly used antiepileptic drug.

## Related Papers

- Author: Depienne C et al.
  *Title: Genetic and clinical aspects of SCN1A and SCN1B epilepsy genes 
  *DOI: [10.1016/S1474-4422(09)70110-5]([Click](https://doi.org/10.1016/S1474-4422(09)70110-5))

- Author: Klassen T et al. 
  *Title: Genetic variants in SCN1B are associated with susceptibility to schizophrenia 
  *DOI: [10.1038/ng.895]([Click](https://doi.org/10.1038/ng.895))

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**